To investigate the subcellular localization of VANGL2, we initially examined HCC1569 cells, a highly proliferative, HER2+ breast cancer cell line that expresses high levels of Vangl2 (Supplementary Figure S1A) [31,32]. Here, ERBB2 is linked to breast carcinoma.